![]() |
市場調查報告書
商品編碼
1491626
Angio Suite 市場:按類型、技術、自動化程度、應用、最終用戶 - 2024-2030 年全球預測Angio Suites Market by Type (Fixed Angio Suites, Mobile Angio Suites), Technology (Computed Tomography Angiography, Digital Subtraction Angiography, Magnetic Resonance Angiography), Level of Automation, Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年Angio Suites市場規模為225.7億美元,預估2024年將達248.4億美元,2030年將達454.5億美元,複合年成長率為10.51%。
血管造影室或血管造影術室是專門為執行血管成像程序(稱為血管造影術)而設計的設施。這些程序可以幫助醫生觀察身體不同部位的血管,並診斷和治療阻塞和異常等疾病。它們通常包括 X 光成像設備和其他診斷工具,使醫療保健專業人員能夠精確地查看和治療目標區域。簡而言之,血管套件對於推廣治療血管疾病的微創技術至關重要。隨著冠狀動脈疾病和周邊動脈疾病等心血管疾病在全球的盛行率持續上升,對血管套件的需求不斷增加。對配備高精度儀器的更先進的血管套件的需求日益成長,因為這些設施對於執行這些疾病通常需要的微創手術至關重要。然而,與血管攝影套件相關的高成本是公司面臨的主要挑戰。此外,血管攝影套件中成像技術增強功能(例如高解析度相機和即時成像軟體)的市場開拓為市場成長提供了重大機會。這些進步提高了血管和介入手術的精確度和效率,增加了對配備最新技術的最先進血管套件的需求。
主要市場統計 | |
---|---|
基準年[2023] | 225.7億美元 |
預測年份 [2024] | 248.4億美元 |
預測年份 [2030] | 454.5億美元 |
複合年成長率(%) | 10.51% |
區域洞察
美國市場,尤其是美國和加拿大,心血管疾病盛行率高,醫療保健支出高,導致血管治療套件的採用率增加。該地區擁有完善的醫療基礎設施,並且高度重視研究和創新,加速了先進醫療技術的採用。最近的投資重點是整合人工智慧和機器人技術,以提高血管造影術手術的準確性和效率。同時,歐洲、中東和非洲地區的醫療保健設施的現代化和擴張呈現強勁的趨勢,包括更新現有的血管造影術系統。德國、法國和英國等國家因其強大的醫療保健系統和積極參與臨床研究而成為該技術的主要採用者。最近的歐盟醫療設備(MDR) 法規也影響了市場動態,確保了更高的安全和品質標準。此外,亞太地區為 AngioSuites 帶來了巨大的成長潛力。由於重大的醫療改革和醫療基礎設施投資的增加,中國市場正在迅速擴張。日本老年人口對心血管治療表現出持續的需求,並大力投資於技術先進的血管治療套件。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在 Angio Suites 市場中的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一個綜合工具,可以對 Angio Suites 市場中供應商的當前狀態進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對 Angio Suites 市場目前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[180 Pages Report] The Angio Suites Market size was estimated at USD 22.57 billion in 2023 and expected to reach USD 24.84 billion in 2024, at a CAGR 10.51% to reach USD 45.45 billion by 2030.
Angio suites, or angiography suites, are specialized facilities designed for performing vascular imaging procedures known as angiographies. These procedures help doctors visualize blood vessels in various parts of the body to diagnose and treat conditions such as blockages or abnormalities. The suite typically includes equipment for X-ray imaging and other diagnostic tools that help healthcare professionals view and treat the areas of interest with precision. In essence, angio suites are crucial in facilitating minimally invasive techniques for treating vascular diseases. As the prevalence of cardiovascular conditions such as coronary artery diseases and peripheral artery diseases continues to rise globally, there is an amplified demand for angio suites. These facilities are essential for performing minimally invasive surgeries that these conditions often require, thus driving the need for more advanced angio suites equipped with high-precision instruments. However, the high cost associated with the angio suites is a significant challenge faced by the companies. Moreover, the development of enhanced imaging technologies in angio suites, such as higher-resolution cameras and real-time imaging software, offers significant opportunities for market growth. These advancements improve the accuracy and efficiency of vascular and interventional procedures, thereby increasing the demand for modern angio suites equipped with the latest technology.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 22.57 billion |
Estimated Year [2024] | USD 24.84 billion |
Forecast Year [2030] | USD 45.45 billion |
CAGR (%) | 10.51% |
Regional Insights
The American market, particularly the United States and Canada, has been significant in the adoption of angio suites due to the high prevalence of cardiovascular diseases and significant healthcare spending. The region has an established healthcare infrastructure and a strong emphasis on research and innovation, accelerating the adoption of advanced medical technologies. Recent investments have focused on integrating AI and robotic technologies to enhance the precision and efficiency of angiographic procedures. At the same time, in the EMEA, there is a strong trend toward modernizing and expanding healthcare facilities, which includes updating existing angiography systems. Countries including Germany, France, and the United Kingdom are major in technology adoption due to their robust healthcare systems and active participation in clinical research. Recent EU regulations on medical devices (MDR) have also ensured higher safety and quality standards, influencing the market dynamics. Moreover, the Asia Pacific region demonstrates significant growth potential for angio suites. China's market is expanding rapidly due to large-scale healthcare reforms and increasing investment in healthcare infrastructure. Japan's older population shows sustained demand for cardiovascular procedures, thereby investing heavily in technologically advanced angio suites.
Market Insights
The market dynamics represent an ever-changing landscape of the Angio Suites Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Angio Suites Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Angio Suites Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Philips Unveils Enhanced Azurion Neuro Biplane System for Improved Neurovascular Procedures
Philips has upgraded its Azurion image-guided therapy platform by introducing the advanced Azurion neuro biplane system. This new system enhances imaging capabilities and gantry positioning flexibility, optimizing the efficiency of neurovascular interventions. According to a recent press release from the company, the Azurion neuro biplane system aims to increase patient throughput and improve clinical outcomes. [Published On: 2024-02-27]
Enhancing Cardiovascular Health through Innovative Technology Collaboration
Mentice, a player in simulation solutions, and the University Center of Excellence (Unicen) announced a strategic collaboration to advance cardiovascular healthcare technologies. This collaboration integrates Mentice's expertise in high-fidelity simulations with Unicen's clinical research capabilities. The goal is to foster innovations that enhance teaching, improve procedural outcomes, and contribute to safer clinical practices. Such a collaboration promises to accelerate the development of cutting-edge technologies in the cardiovascular field and bridge the gap between clinical research and real-world medical applications, potentially leading to better patient outcomes on a global scale. [Published On: 2024-02-21]
Canon Medical Launches Alphenix / Evolve Edition Angiography System in Europe
Canon Medical released its Alphenix / Evolve Edition angiography system for the European market, featuring real-time Deep Learning technology. This advanced system optimizes image quality and strives to reduce both the duration and radiation exposure during Percutaneous Coronary Intervention (PCI) and Structural Heart Disease (SHD) procedures. Implementing this technology promotes enhanced safety for medical professionals and patients, aiming to lead to more efficient and safer healthcare outcomes in cardiovascular treatments. [Published On: 2023-08-07]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Angio Suites Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Angio Suites Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., Canon Medical Systems Corporation, Carestream Health, Carl-Zeiss-Stiftung, Center for Vascular Diseases, Covenant Health, Esaote S.p.A, FUJIFILM Holdings Corporation, GE Healthcare, Guerbet, Hitachi, Ltd., Hologic, Inc., IMRIS, Inc., Koninklijke Philips N.V., Lam Vascular & Associates, Mentice AB, Mercy Health, MIOT International, Neurotexas, PLLC, ONEX Corporation, PLANMED OY, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers, Spain Commercial, Inc., Surrey and Sussex Healthcare NHS Trust, United Biologics Inc., Universal Health Services, Inc., UTMB Health, and Vascular Surgical Associates.
Market Segmentation & Coverage